Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Walnut Oral Immunotherapy for Tree Nut Allergy

Trial Profile

Walnut Oral Immunotherapy for Tree Nut Allergy

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Walnut allergy immunotherapy (Primary)
  • Indications Food hypersensitivity
  • Focus Therapeutic Use
  • Acronyms WOIT

Most Recent Events

  • 08 Apr 2021 Biomarkers information updated
  • 01 May 2013 Additional trial ID identified and integrated (ClinicalTrials.gov record: NCT01834352).
  • 01 May 2013 Additional trial ID identified and integrated (ClinicalTrials.gov record: NCT01834352).

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top